You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞盛醫藥-B(6855.HK)首日上市高開55%
格隆匯 10-28 09:31
格隆匯10月28日丨創新藥企亞盛醫藥-B(6855.HK)今日首日上市高開55%,開報53港元,盤前成交萬港元,最新總市值109.7億港元。該股IPO定價34.2港元,認購倍數751.99倍。公司主要圍繞細胞凋零領域,研發對抗癌症的辦法,佈局深入,產線廣,代表細胞凋亡主流方向的三種靶點皆有研發,其細胞凋亡標靶療法領域的藥物研發在全球範圍處於前沿。公司董事長楊大俊博士有二十餘年癌症新藥研發與轉化經驗,先後發表學術論文及摘要100多篇,有20多件國內外發明專利。核心團隊成員亦在癌症研究領域擁有豐富經驗。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account